A blood test could detect ETC in living people

A blood test could detect ETC in living people
Credit: Claude

The “Holy Grail” of Concussion Research

A major breakthrough could change the way we understand the effects of football on the brain. A new blood test could detect advanced stages of chronic traumatic encephalopathy (CTE) in living people, according to two recent studies published in the Journal of the American Medical Association (JAMA), as reported by RDS, citing an ESPN article.

Until now, this degenerative brain disease—linked to repeated head impacts in football and other contact sports—could only be diagnosed after death, through an examination of the brain. Scientists studying the link between football and brain damage have long considered diagnosis in living individuals to be the “Holy Grail” of their field.

One of the two studies, published Thursday by researchers at Boston University and Banner Health, is based on a small sample of former football players who had donated blood while they were alive. After their deaths, autopsies of their brains confirmed that they had CTE. The researchers then identified a marker for the disease by analyzing the concentration of a specific protein in these blood samples.

Promising, but only in advanced stages

The study involved 21 deceased players: 12 had played professionally, seven at the collegiate level, and two only at the high school level.

Michael Alosco, co-director of clinical research at Boston University's CTE Center and a co-lead author of the study, describes this as a turning point in the ability to diagnose the disease in living individuals. He says he is cautiously optimistic about the progress that could be made over the next five years.

The test does, however, have a significant limitation: it has shown promise only for detecting advanced stages of CTE, not early stages. The disease is often asymptomatic in its early stages. In advanced stages, patients may experience memory loss, confusion, depression, irritability, and significant mood swings.

This research is part of a broader research effort. In 2025, the U.S. National Institutes of Health awarded a grant of 15.3 million U.S. dollars to a consortium led by Boston University's ETC Center, with participation from the Banner Alzheimer's Institute, to identify blood and imaging markers that can diagnose ETC during a person's lifetime.

The small sample size means that further studies will be needed before such a test can be used in clinical practice.

Sources

Created by humans, assisted by AI.

Share this post

facebook icon twitter icon linkedin icon
Copied!

Popular posts